Shared decision-making and disease management in advanced cancer and chronic kidney disease using patient-reported outcome dashboards.

ABSTRACT:

Objectives

To assess the use of a co-designed patient-reported outcome (PRO) clinical dashboard and estimate its impact on shared decision-making (SDM) and symptomatology in adults with advanced cancer or chronic kidney disease (CKD).

Materials and methods

We developed a clinical PRO dashboard within the Northwestern Medicine Patient-Reported Outcomes system, enhanced through co-design involving 20 diverse constituents. Using a single-group, pretest-posttest design, we evaluated the dashboard's use among patients with advanced cancer or CKD between June 2020 and January 2022. Eligible patients had a visit with a participating clinician, completed at least two dashboard-eligible visits, and consented to follow-up surveys. PROs were collected 72 h prior to visits, including me

SUBMITTER: Cella D 

PROVIDER: S-EPMC11413432 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature